A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2011
12/22/2011	US20110313032 Competitive inhibitors of type ii dehydroquinase enzyme
12/22/2011	US20110313030 Pkr activation via hybridization chain reaction
12/22/2011	US20110313026 Dna and proteins or peptides specific of bacteria of the neisseria meningitidis species, methods for obtaining them and biological applications thereof
12/22/2011	US20110313023 RNAi MODULATION OF RSV AND THERAPEUTIC USES THEREOF
12/22/2011	US20110313022 Compositions and Methods for Diminishing Viral Infection and Inflammation Associated with Viral Infection
12/22/2011	US20110313020 UsiRNA Complexes
12/22/2011	US20110313016 Treatment of Intestinal Conditions
12/22/2011	US20110312996 Novel inhibitors of hepatitis c virus replication
12/22/2011	US20110312989 Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
12/22/2011	US20110312987 Salt of naphthyridine carboxylic acid derivative
12/22/2011	US20110312985 Naringenin complexes and methods of use thereof
12/22/2011	US20110312984 Stat3 inhibitors
12/22/2011	US20110312977 Process for the preparation of voriconazole
12/22/2011	US20110312973 Solid compositions
12/22/2011	US20110312960 Pyrazine derivatives and use as pi3k inhibitors
12/22/2011	US20110312957 Imidazopyridines and imidazopyrimidines as hiv-i reverse transcriptase inhibitors
12/22/2011	US20110312940 Tetra-aza-heterocycles as phosphatidylinositol-3-kinases (p13-kinases) inhibitor
12/22/2011	US20110312939 New chemical compounds
12/22/2011	US20110312936 Cyclohexyl-azetidinyl antagonists of ccr2
12/22/2011	US20110312935 1H-Benz Imidazole-5-Carboxamides As Anti-Inflammatory Agents
12/22/2011	US20110312922 EDTA Resistant S100A12 Complexes (ERAC)
12/22/2011	US20110312921 N-Myristoyl Transferase Inhibitors
12/22/2011	US20110312920 Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same
12/22/2011	US20110312880 Potent chimeric nrti-nnrti bifunctional inhibitors of hiv-1 reverse transcriptase
12/22/2011	US20110312879 Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity
12/22/2011	US20110312878 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
12/22/2011	US20110312877 Engineered tunable nanoparticles for delivery of therapeutics, diagnostics, and experimental compounds and related compositions for therapeutic use
12/22/2011	US20110312876 Method of determining types I, II, III, IV or V or methicillin-resistant staphylococcus aureus (MRSA) in a biological sample
12/22/2011	US20110312875 Peptidic compounds
12/22/2011	US20110312873 N-terminally modified tetrapeptide derivatives having a c-terminal arginine mimetic
12/22/2011	US20110311659 Composition and method of treating lipid encapsulated virus infections
12/22/2011	US20110311656 Antimicrobial composition based on botanical extracts from oil palm vegetation liquor
12/22/2011	US20110311647 Biofilm-removing antimicrobial compositions and uses thereof
12/22/2011	US20110311634 Formulations for animal feed comprising butyrate salt
12/22/2011	US20110311629 Non-adhesive elastic gelatin matrices
12/22/2011	US20110311628 Pulsatile release composition of therapeutic agent
12/22/2011	US20110311626 Controlled release compositions comprising anti-cholinergic drugs
12/22/2011	US20110311617 Oral vaccine
12/22/2011	US20110311615 Novel gp41 antigens
12/22/2011	US20110311614 Splitting gp41
12/22/2011	US20110311612 Humanized Neuraminidase Antibody and Methods of Use Thereof
12/22/2011	US20110311611 Water dissolvable adherent article for topical application
12/22/2011	US20110311592 Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
12/22/2011	US20110311591 Antimicrobial Coating
12/22/2011	US20110311589 Compositions and dosage regimes comprising a clostridial vaccine and levamisole
12/22/2011	US20110311588 Agents and treatment for snoring and respiratory effort related arousals in sleep
12/22/2011	US20110311587 Fusogenic virus-like particles and uses thereof
12/22/2011	US20110311586 Materials and methods for respiratory disease control in canines
12/22/2011	US20110311585 Therapeutic compositions and methods for treating HIV including identification and manipulation of particular domains associated with immunogenicity
12/22/2011	US20110311584 Use of flt3 ligand for enhancing immune responses in rna immunization
12/22/2011	US20110311583 Novel lipids and compositions for the delivery of therapeutics
12/22/2011	US20110311582 Novel lipids and compositions for the delivery of therapeutics
12/22/2011	US20110311580 Settings for recombinant adenoviral-based vaccines
12/22/2011	US20110311579 Flaviviruses expressing the prM, E, and NS1 proteins of other flaviviruses and uses thereof
12/22/2011	US20110311578 Recombinant inactivated viral vector vaccine
12/22/2011	US20110311577 Method of producing a vaccine
12/22/2011	US20110311576 Mixing lyophilised meningococcal vaccines with non-hib vaccines
12/22/2011	US20110311575 MIXING LYOPHILISED MENINGOCOCCAL VACCINES WITH D-T-Pa VACCINES
12/22/2011	US20110311573 Method for Preparing Recombinant Antigen Complex Using Rotavirus Nanoparticle
12/22/2011	US20110311570 Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species
12/22/2011	US20110311569 HIV-1 Peptides, Nucleic Acids, and Compositions and Uses Thereof
12/22/2011	US20110311568 Vaccine
12/22/2011	US20110311564 Method for Producing Intermediates for the Production of Novel Macrocycles that are Inhibitors of the Proteasomic Degradation of p27, such as Argyrin and Derivatives Thereof, and Uses of Said Macrocycles
12/22/2011	US20110311563 Synthetic Antigenic Peptides and Lipopeptides Derived from Mycobacterium Avium Subsp. Paratubuerculosis
12/22/2011	US20110311562 Glycolipid Mixture with Anti-Inflammatory Activity Obtained from Oscillatoria Planktothrix
12/22/2011	US20110311561 Non-natural mic proteins
12/22/2011	US20110311551 Antibodies directed against hepatitis c virus e1e2 complex, compositions of hcv particles, and pharmaceutical compositions
12/22/2011	US20110311550 Agents for hcv treatment
12/22/2011	US20110311541 Mutant proteins of the f protein of piv-5 and piv-2
12/22/2011	US20110311532 Inhibition of complement and cellular activation
12/22/2011	US20110311531 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/22/2011	US20110311530 Truncated baff receptors
12/22/2011	US20110311523 Platelet derived growth factor receptor supports cytomegalovirus infectivity
12/22/2011	US20110311522 Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof
12/22/2011	US20110311518 Novel synthetic agonists of tlr9
12/22/2011	US20110311516 Chemically Programmed Vaccination
12/22/2011	US20110311508 Method of modulating hsf-1
12/22/2011	US20110311499 Secretion System and Methods for its Use
12/22/2011	US20110311488 Modified bacterial cell
12/22/2011	US20110311485 1,2,4-oxadiazole derivatives and their therapeutic use
12/22/2011	US20110311484 Strains of xenotropic murine leukemia-related virus and methods for detection thereof
12/22/2011	US20110311482 Hepatitis C Virus Inhibitors
12/22/2011	US20110311480 Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
12/22/2011	US20110311479 Modulators of indoleamine 2,3-dioxygenase and methods of using the same
12/22/2011	US20110311462 Compositions for treatment of ear disorders and methods of use thereof
12/22/2011	US20110311454 Molecules with extended half-lives, compositions and uses thereof
12/22/2011	US20110311451 Synthesis of polymer conjugates of indolocarbazole compounds
12/22/2011	US20110311449 Antibodies
12/22/2011	US20110311442 Direct cellular energy delivery system
12/22/2011	DE10344561B4 Verwendung eines Tetra-, Penta- und Octapeptids aus Gelée Royale Use of tetra-, penta- and octapeptide of royal jelly
12/22/2011	CA2839421A1 Antibodies useful in passive influenza immuization
12/22/2011	CA2839420A1 High affinity human antibodies to human cytomegalovirus (cmv) gb protein
12/22/2011	CA2805409A1 Pla2g16 as a target for antiviral compounds
12/22/2011	CA2803317A1 Novel formulation of pegylated-liposome encapsulated glycopeptide antibiotics
12/22/2011	CA2802665A1 Peptide having antibacterial or anti-inflammatory activity and pharmaceutical composition containing the same as an active ingredient
12/22/2011	CA2802529A1 Carbapenem antibacterials with gram-negative activity
12/22/2011	CA2802477A1 Agent for treating hcv infection
12/22/2011	CA2790294A1 .alpha.-crystalline form of carbabenzpyride
12/21/2011	EP2397555A1 Fusion proteins of mycobacterium tuberculosis antigens and their uses
12/21/2011	EP2397547A1 Drug transporter, and adjuvant and vaccine each utilizing same

1 ... 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 ... 1798